Why it Matters
Centene’s new lobbying engagement signals the company is ramping up influence efforts on Medicare, Medicaid and ACA marketplace issues as enhanced premium tax credits face a 2025 deadline. Continental Strategy adds Republican connections through former GOP Chief of Staff Timothy Costa.
By the Numbers
- Q3 2025 spending: $105,000 to Continental Strategy LLC
- Historical investment: $46.74 million total lobbying spend since 2006
- $36.87 million through in-house team
- $9.87 million through external firms
- Lobbying team: Timothy M. Costa and Paul F. Calkins Jr.
Broader Context
Enhanced ACA premium tax credits expire at the end of 2025. Without extension, millions could face large premium increases on marketplace plans. This directly impacts Centene’s core business in ACA exchanges. Democrats have introduced legislation to make the credits permanent while Republicans argue the ACA has failed to reduce costs.
The Agenda
Centene is seeking “strategic guidance and counsel related to Medicare, Medicaid, and the health insurance market.” Key issues include ACA marketplace regulations, Medicare Advantage rates, and Medicaid managed care policies. No specific legislation was identified in the filing.
Competitive Landscape
Centene faces intense lobbying competition from industry rivals. UnitedHealth Group and Elevance Health reported significant in-house lobbying spend in 2025 Q2. Trade groups such as America’s Health Insurance Plans and various Blue Cross Blue Shield entities also lobby heavily on ACA tax credits.
Between The Lines
Congress is actively debating healthcare policy. The House Ways and Means Committee held hearings on Medicare Advantage opportunities, and lawmakers have introduced bills like the Health Care Affordability Act. Lawmakers on both sides of the aisle are vocal about Medicaid funding and rural healthcare access.
The Bottom Line
Centene’s Continental Strategy hire reflects preparation for critical 2025 healthcare debates. The company seeks Republican access through Costa’s Hill experience; success depends on navigating partisan divisions over ACA funding and Medicaid policy. The outcome will significantly impact Centene’s government-sponsored insurance business.
Spot something wrong? Report an issue with this article